Dna X (SONM) Operating Expenses (2018 - 2026)

Dna X has reported Operating Expenses for 9 years, with the latest figure at $3.6 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 315.86% year-over-year to $3.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (up 181.0% YoY), and the FY2025 full-year result was $5.4 million, up 74.39% from the prior year.
• Operating Expenses for Q1 2026 stood at $3.6 million, up from -$15.7 million in the prior quarter.
• The five-year high for Operating Expenses was $9.4 million in Q2 2024, with the low at -$18.5 million in Q4 2024.
• Historically, Operating Expenses has averaged $2.9 million across 5 years, with a median of $5.2 million in 2022.
• Annual changes were most pronounced in 2024 — Operating Expenses sank 390.79% — and 2026, when it soared 315.86%.
• Dna X's Operating Expenses stood at $5.0 million in 2022, then advanced by 27.73% to $6.4 million in 2023, then slumped by 390.79% to -$18.5 million in 2024, then climbed by 15.43% to -$15.7 million in 2025, then soared by 123.08% to $3.6 million in 2026.
• The last three Operating Expenses figures came in at $3.6 million (Q1 2026), -$15.7 million (Q4 2025), and $5.8 million (Q3 2025), per Business Quant data.